<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04737187</url>
  </required_header>
  <id_info>
    <org_study_id>CL3-95005-007</org_study_id>
    <secondary_id>2020-001976-14</secondary_id>
    <nct_id>NCT04737187</nct_id>
  </id_info>
  <brief_title>Phase III Study of Trifluridine/Tipiracil in Combination With Bevacizumab vs Trifluridine/Tipiracil Single Agent in Patients With Refractory Metastatic Colorectal Cancer</brief_title>
  <acronym>SUNLIGHT</acronym>
  <official_title>An Open-label, Randomized, Phase III Study Comparing Trifluridine/Tipiracil in Combination With Bevacizumab to Trifluridine/Tipiracil Monotherapy in Patients With Refractory Metastatic Colorectal Cancer (SUNLIGHT Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taiho Oncology, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut de Recherches Internationales Servier</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Taiho Oncology, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed as an international, open-label, controlled two-arm, randomized phase&#xD;
      III comparison study evaluating the efficacy and safety of trifluridine/tipiracil in&#xD;
      combination with bevacizumab versus trifluridine/tipiracil monotherapy in patients with&#xD;
      refractory mCRC.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an international, open-label, controlled two-arm, randomised phase III study&#xD;
      evaluating the efficacy and safety of trifluridine/tipiracil in combination with bevacizumab&#xD;
      versus trifluridine/tipiracil monotherapy in patients with refractory mCRC. The analysis will&#xD;
      be done after 331 events are reported. In order to observe this number of events, 490&#xD;
      patients will be randomised (1:1) to receive trifluridine/tipiracil in combination with&#xD;
      bevacizumab (experimental arm) or trifluridine/tipiracil monotherapy (control arm).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 25, 2020</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall Survival (OS)</measure>
    <time_frame>Approximately 12 months</time_frame>
    <description>Overall survival defined as the observed time elapsed between the date of randomization and the date of death due to any cause</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Progression-free survival (PFS)</measure>
    <time_frame>Approximately 12 months</time_frame>
    <description>Progression-free survival defined as the time elapsed between the randomization and the date of radiologic tumour progression according to RECIST version 1.1 (Eisenhauer, 2009) by investigator's judgement or death from any cause, whichever comes first.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall response rate (ORR)</measure>
    <time_frame>Approximately 12 months</time_frame>
    <description>Overall response rate defined as the proportion of patients with objective evidence of complete response (CR) or partial response (PR) according to RECIST version 1.1 criteria and using investigator's tumor assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease control rate (DCR)</measure>
    <time_frame>Approximately 12 months</time_frame>
    <description>Disease control rate defined as the proportion of patients with objective evidence of CR or PR or stable disease (SD) according to RECIST version 1.1 criteria and using investigator's tumor assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment-emergent adverse events (TEAEs) as assessed by CTCAE v5.0, including serious adverse events (SAEs) for safety and tolerability assessment of study drug(s)</measure>
    <time_frame>Approximately 12 months</time_frame>
    <description>Treatment-emergent adverse events (TEAEs) as assessed by CTCAE v5.0, including serious adverse events (SAEs)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life: EORTC QLQ-C30</measure>
    <time_frame>Approximately 12 months</time_frame>
    <description>Assess patients health and activities using the European Organization for Research and Treatment of Cancer Core Quality of Life (EORTC QLQ-C30) module.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life: EQ-5D-5L</measure>
    <time_frame>Approximately 12 months</time_frame>
    <description>Assess patients health and activities using the European Organization for Research and Treatment of Cancer Core Quality of Life (EQ-5D-5L) module.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">490</enrollment>
  <condition>Refractory Metastatic Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>trifluridine/tipiracil in combination with bevacizumab</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>trifluridine/tipiracil monotherapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Trifluridine/Tipiracil</intervention_name>
    <description>Taken by mouth two times a day, 5 days on/2 days off, over 2 weeks, followed by a 14-day rest</description>
    <arm_group_label>trifluridine/tipiracil in combination with bevacizumab</arm_group_label>
    <arm_group_label>trifluridine/tipiracil monotherapy</arm_group_label>
    <other_name>TAS102</other_name>
    <other_name>S 95005</other_name>
    <other_name>Lonsurf</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bevacizumab</intervention_name>
    <description>administered every 2 weeks (Day 1 and Day 15)</description>
    <arm_group_label>trifluridine/tipiracil in combination with bevacizumab</arm_group_label>
    <other_name>Avastin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Has histologically confirmed unresectable adenocarcinoma of the colon or rectum (all&#xD;
             other histological types are excluded).&#xD;
&#xD;
          2. RAS status must have been previously determined (mutant or wild-type) based on local&#xD;
             assessment of tumor biopsy.&#xD;
&#xD;
          3. Has received a maximum of 2 prior chemotherapy regimens for the treatment of advanced&#xD;
             colorectal cancer and had demonstrated progressive disease or intolerance to their&#xD;
             last regimen.&#xD;
&#xD;
          4. Has measurable or non-measurable disease as defined by RECIST version 1.1&#xD;
&#xD;
          5. Is able to swallow oral tablets.&#xD;
&#xD;
          6. Estimated life expectancy ≥12 weeks.&#xD;
&#xD;
          7. Eastern Cooperative Oncology Group performance status (ECOG PS) 0 or 1&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. More than 2 prior chemotherapy regimens for the treatment of advanced colorectal&#xD;
             cancer.&#xD;
&#xD;
          2. Pregnancy, lactating female or possibility of becoming pregnant during the study.&#xD;
&#xD;
          3. Patients currently receiving or having received anticancer therapies within 4 weeks&#xD;
             prior to randomization.&#xD;
&#xD;
          4. Has not recovered from clinically relevant non-hematologic CTCAE grade ≥ 3 toxicity of&#xD;
             previous anticancer therapy prior to randomization (excluding alopecia, and skin&#xD;
             pigmentation).&#xD;
&#xD;
          5. Has symptomatic central nervous system metastases that are neurologically unstable or&#xD;
             requiring increasing doses of steroids to control CNS disease.&#xD;
&#xD;
          6. Has severe or uncontrolled active acute or chronic infection.&#xD;
&#xD;
          7. Has active or history of interstitial lung disease and/or pneumonitis, or pulmonary&#xD;
             hypertension.&#xD;
&#xD;
          8. Known Hepatitis B or Hepatitis C Virus infection.&#xD;
&#xD;
          9. Known carriers of HIV antibodies.&#xD;
&#xD;
         10. Confirmed uncontrolled arterial hypertension (defined as systolic blood pressure ≥ 150&#xD;
             mm Hg and/or diastolic blood pressure ≥ 100 mm Hg) or uncontrolled or symptomatic&#xD;
             arrhythmia.&#xD;
&#xD;
         11. Deep arterial thromboembolic events including cerebrovascular accident or myocardial&#xD;
             infarction within the last 6 months prior to randomization.&#xD;
&#xD;
         12. Treatment with any of the following within the specified time frame prior to&#xD;
             randomization:&#xD;
&#xD;
               -  major surgery within 4 weeks prior to randomisation (the surgical incision should&#xD;
                  be fully healed prior to study drug administration), or has not recovered from&#xD;
                  side effects of previous surgery, or patient that may require major surgery&#xD;
                  during the study&#xD;
&#xD;
               -  Prior radiotherapy if completed less than 4 weeks before randomisation, except if&#xD;
                  provided as a short course for symptoms palliation only.&#xD;
&#xD;
               -  Drainage for ascites, pleural effusion or pericardial fluid within 4 weeks prior&#xD;
                  to randomization&#xD;
&#xD;
         13. Other clinically significant medical conditions.&#xD;
&#xD;
         14. Other malignancies.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Josep Tabernero, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vall d'Hebron Institute of Oncology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karim Benhadji, MD</last_name>
    <phone>609-250-7336</phone>
    <email>clinicaltrialinfo@taihooncology.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mayo Clinic - AZ</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85054</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Heeney</last_name>
      <phone>855-776-0015</phone>
      <email>cancerclinicaltrialsreferrals@mayo.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>City of Hope</name>
      <address>
        <city>Duarte</city>
        <state>California</state>
        <zip>91010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>City of Hope - South Pasedena</name>
      <address>
        <city>South Pasadena</city>
        <state>California</state>
        <zip>91030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>City of Hope - Upland</name>
      <address>
        <city>Upland</city>
        <state>California</state>
        <zip>91786</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Florida Cancer Specialists</name>
      <address>
        <city>Fort Myers</city>
        <state>Florida</state>
        <zip>33901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vance Wright-Browne</last_name>
      <phone>239-274-9930</phone>
      <email>clinicaltrials@flcancer.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic - FL</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Arnold</last_name>
      <phone>904-953-3652</phone>
      <email>Arnold.amanda1@mayo.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Comprehensive Cancer Center</name>
      <address>
        <city>Miami Beach</city>
        <state>Florida</state>
        <zip>33140</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Florida Cancer Specialists</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gail Wright</last_name>
      <phone>727-216-1143</phone>
      <email>clinicaltrials@flcancer.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Comprehensive Hematology Oncology</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33709</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Florida Cancer Specialists</name>
      <address>
        <city>Tallahassee</city>
        <state>Florida</state>
        <zip>32308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Viralkumar Bhanderi</last_name>
      <phone>850-877-8166</phone>
      <email>Vbhanderi@flcancer.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Florida Cancer Specialists</name>
      <address>
        <city>West Palm Beach</city>
        <state>Florida</state>
        <zip>33401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jenifer Bar-Nur</last_name>
      <phone>561-472-1696</phone>
      <email>Jbar-nur@flcancer.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>DuPage Medical Group - Joliet Oncology-Hematology Associates</name>
      <address>
        <city>Joliet</city>
        <state>Illinois</state>
        <zip>60435</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aditya Bardia</last_name>
      <phone>617-724-4800</phone>
      <email>Abardia1@partners.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dana Farber Cancer Institute</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>DF Trial Hotline</last_name>
      <phone>877-338-7425</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic - MN</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Ihrke</last_name>
      <phone>507-538-5843</phone>
    </contact>
    <contact_backup>
      <last_name>Paige Schreifels</last_name>
      <phone>507-266-0539</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>HCA Midwest Health</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Stieben</last_name>
      <phone>816-276-4626</phone>
      <email>Susan.Johnson4@hcamidwest.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oncology Hematology West, PC dba Nebraska Cancer Specialists</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Tennessee Oncology</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ask Sarah Hotline</last_name>
      <phone>844-482-4812</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tennessee Oncology</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ask Sarah Hotline</last_name>
      <email>asksarah@scresearch.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UT Southwestern</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nisha Unni Melanie Hullings</last_name>
      <phone>214-648-4180</phone>
      <email>Nisha.Unni@UTSouthwestern.edu</email>
    </contact>
    <contact_backup>
      <last_name>Melanie Hullings</last_name>
      <phone>214-648-7097</phone>
      <email>Melanie.Hullings@UTSouthwestern.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>MD Anderson</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Senthil Damodaran</last_name>
      <phone>713-792-2817</phone>
      <email>sdamodaran@mdanderson.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>&quot;Medizinische Universität Graz &quot;</name>
      <address>
        <city>Graz</city>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Medizinische Universität Innsbruck Univ.-Klinik für Innere Medizin V&quot;</name>
      <address>
        <city>Innsbruck</city>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Ordensklinikum Linz Barmherzige Schwestern Interne I&quot;</name>
      <address>
        <city>Linz</city>
        <zip>4010</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Landeskrankenhaus Feldkirch Interne E&quot;</name>
      <address>
        <city>Rankweil</city>
        <zip>6830</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Landeskrankenhaus (SALK) Universitätsklinik für Innere Medizin III (SALK)&quot;</name>
      <address>
        <city>Salzburg</city>
        <zip>5020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Landesklinikum Wiener Neustadt &quot;</name>
      <address>
        <city>Wiener Neustadt</city>
        <zip>2700</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Allgemeines Krankenhaus - Universitätskliniken Klinische Abteilung für Onkologie&quot;</name>
      <address>
        <city>Wien</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;OLV Ziekenhuis Oncology&quot;</name>
      <address>
        <city>Aalst</city>
        <zip>9300</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Universitair Ziekenhuis Antwerpen Oncologie&quot;</name>
      <address>
        <city>Edegem</city>
        <zip>2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;UZ Leuven Campus Gasthuisberg Digestieve Oncologie&quot;</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;CHC Montlégia Oncologie&quot;</name>
      <address>
        <city>Liege</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;AZ NIKOLAAS Oncology&quot;</name>
      <address>
        <city>Sint Niklaas</city>
        <zip>9100</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Hospital do Câncer de Barretos - Fundação Pio XII Unidade de Pesquisa Clínica&quot;</name>
      <address>
        <city>Barretos</city>
        <zip>14784-400</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Hospital de Base Centro Integrado de Pesquisa&quot;</name>
      <address>
        <city>Sao Jose Do Rio Preto</city>
        <zip>15090-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;ICESP - Instituto do Câncer do Estado de São Paulo Centro Integrado de Pesquisa&quot;</name>
      <address>
        <city>Sao Paulo</city>
        <zip>01246-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Hospital A C Camargo Unidade de Pesquisa Clinica&quot;</name>
      <address>
        <city>Sao Paulo</city>
        <zip>01509-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Instituto Brasileiro de Controle do Câncer Unidadde de Pesquisa Clínica&quot;</name>
      <address>
        <city>Sao Paulo</city>
        <zip>03102-002</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Hospital Albert Einstein Instituto de Ensino e Pesquisa&quot;</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05652- 900</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Aalborg Universitetshospital, Syd Onkologisk Afdeling&quot;</name>
      <address>
        <city>Aalborg</city>
        <zip>9000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet Dpt of Oncology</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Regionshospitalet Herning, Hospitalsenheden Vest Onkologisk Afdeling&quot;</name>
      <address>
        <city>Herning</city>
        <zip>7400</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Odense Universitetshospital Department of Oncology&quot;</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;CHU Jean Minjoz Service d'oncologie médicale&quot;</name>
      <address>
        <city>Besancon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;CHU Morvan Institut de Cancérologie et d'Hématologie&quot;</name>
      <address>
        <city>Brest</city>
        <zip>29200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Centre de lutte contre le cancer Francois Baclesse UCP Digestif&quot;</name>
      <address>
        <city>Caen</city>
        <zip>14076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Hôpital Saint-Antoine Service d'Oncologie Médicale&quot;</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Hôpital Européen Georges Pompidou Oncologie Hépatogastroenterologie-oncologie digestive&quot;</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;CHU de Poitiers Pole Régional de Cancérologie&quot;</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Onkologische Schwerpunktpraxis Kurfuerstendamm &quot;</name>
      <address>
        <city>Berlin</city>
        <zip>10707</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Charite Universitätsmedizin Medizinische Klinik m.S. Haemat., Onko., Tumorimmunologie&quot;</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Lübecker Onkologische Schwerpunktpraxis im Hochschulstadttei &quot;</name>
      <address>
        <city>Luebeck</city>
        <zip>23562</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Klinikum der Universität München Campus Großhadern, Medizinische Klinik und Poliklinik III&quot;</name>
      <address>
        <city>Muenchen</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Magyar Honvedseg Egeszsegugyi Kozpont Onkologiai Osztaly&quot;</name>
      <address>
        <city>Budapest</city>
        <zip>1062</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Szent Imre Egyetemi Oktatokorhaz Klinikai Onkologiai Osztaly&quot;</name>
      <address>
        <city>Budapest</city>
        <zip>1115</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Orszagos Onkologiai Intezet &quot;&quot;B&quot;&quot; Belgyogyaszati-Onkologiai O. Es Klin. Farmakologiai O.&quot;</name>
      <address>
        <city>Budapest</city>
        <zip>1122</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Debreceni Egyetem Orvos es Egeszsegtudomanyi Centrum Onkologiai Intezet&quot;</name>
      <address>
        <city>Debrecen</city>
        <zip>4032</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Bekes Megyei Kozponti Korhaz Onkologia&quot;</name>
      <address>
        <city>Gyula</city>
        <zip>5700</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Petz Aladar Megyei Oktato Korhaz Onkoradiologiai Osztaly</name>
      <address>
        <city>Győr</city>
        <zip>9024</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kp. Onkoterápiás Klinika&quot;</name>
      <address>
        <city>Szeged</city>
        <zip>6720</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;JNSZ Megyei Hetenyi Geza Korhaz es Rendelointezet Megyei Onkologiai Centrum&quot;</name>
      <address>
        <city>Szolnok</city>
        <zip>5004</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Markusovszky Egyetemi Oktatokorhaz Onkoradiologiai Osztaly&quot;</name>
      <address>
        <city>Szombathely</city>
        <zip>9700</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Oncologia Medica A.O. Universitaria di Cagliari Policlinico Universitario &quot;Duilio Casula&quot; di Monserrato&quot;</name>
      <address>
        <city>Monserrato</city>
        <zip>9042</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>S.C. di Oncologia Medica Addominale Istituto Nazionale Tumori IRCCS &quot;&quot;Fondazione G. Pascale&quot;&quot;&quot;</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>S.C. di Oncologia Medica Addominale Istituto Nazionale Tumori IRCCS &quot;Fondazione G. Pascale&quot;</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>U.O.C. OncoEmatologia Dipartimento di Medicina di Precisione c/o Nuovo Policlinico Università degli studi della Campania &quot;Luigi Vanvitelli&quot;</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Unità Operativa Complessa Oncologia Medica 1 Istituto Oncologico Veneto - IRCCS&quot;</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;U.O. di Oncologia Medica Polo Oncologico Edificio 22 Stabilimento Santa Chiara AZ. Osped. Universitaria Pisana&quot;</name>
      <address>
        <city>Pisa</city>
        <zip>56126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;U.O. Oncologia Medica Azienda Ospedaliera Regionale - Potenza Ospedale &quot;&quot;San Carlo&quot;&quot; - Potenza&quot;</name>
      <address>
        <city>Potenza</city>
        <zip>85100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;S.C. Oncologia - Responsabile S.S. Sperimentazioni Cliniche ASMN - IRCCS di Reggio Emilia&quot;</name>
      <address>
        <city>Reggio Emilia</city>
        <zip>42123</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Unità Operativa di Oncologia ed Ematologia Istituto Clinico Humanitas&quot;</name>
      <address>
        <city>Rozzano (MI)</city>
        <zip>71013</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Dipartimento di Onco-Ematologia Ospedale IRCSS Casa Sollievo della Sofferenza&quot;</name>
      <address>
        <city>San Giovanni Rotondo</city>
        <zip>71013</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Przychodnia Lekarska &quot;&quot;KOMED&quot;&quot; &quot;</name>
      <address>
        <city>Konin</city>
        <zip>62-500</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;SP ZOZ Szpital Uniwersytecki w Krakowie Oddzial Kliniczny Onkologii&quot;</name>
      <address>
        <city>Krakow</city>
        <zip>31-531</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Opolskie Centrum Onkologii im. Tadeusza Koszarowskiego Oddzial Onkologii Klinicznej&quot;</name>
      <address>
        <city>Opole</city>
        <zip>45-061</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Wojewodzki Szpital Specjalistyczny im. Janusza Korczaka w Slupsku Sp. z o.o.&quot;</name>
      <address>
        <city>Słupsk</city>
        <zip>76-200</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy Klinika Onkologii i Radioterapii&quot;</name>
      <address>
        <city>Warszawa</city>
        <zip>02-034</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Wojskowy Instytut Medyczny Klinika Onkologii&quot;</name>
      <address>
        <city>Warszawa</city>
        <zip>04-141</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Centralny Szpital Kliniczny MSWiA Oddział Radioterapii i Onkologii&quot;</name>
      <address>
        <city>Warzszawa</city>
        <zip>02-507</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Pan American Center for Oncology Trials, LLC</name>
      <address>
        <city>Río Piedras</city>
        <zip>00935</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Arkhangelsk Clinical Oncology Dispensary chemotherapy department&quot;</name>
      <address>
        <city>Arkhangelsk</city>
        <zip>163045</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Clinical Oncology Dispensary No.1 Chemotherapy Department&quot;</name>
      <address>
        <city>Krasnodar</city>
        <zip>350040</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Kursk Regional Clinical Oncology Dispensary General Oncology Department&quot;</name>
      <address>
        <city>Kursk</city>
        <zip>305524</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Moscow City Oncology Hospital # 62 chemotherapy department&quot;</name>
      <address>
        <city>Moscow Region</city>
        <zip>143423</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Russian Cancer Research Center n.a. NN Blokhin Clinical Pharmacology and Chemotherapy&quot;</name>
      <address>
        <city>Moscow</city>
        <zip>115478</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;University Headache Clinic Outpatient oncology clinic&quot;</name>
      <address>
        <city>Moscow</city>
        <zip>121467</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;National Medical Research Centre of Radiology Moscow Research Oncology Institute N.A. Herzen&quot;</name>
      <address>
        <city>Moscow</city>
        <zip>125284</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Omsk Clinical Oncologic Dispensary Chemotherapy&quot;</name>
      <address>
        <city>Omsk</city>
        <zip>644046</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;National Medical Research Center of Oncology N.N. Petrova &quot;</name>
      <address>
        <city>Saint-petersburg</city>
        <zip>197758</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Multidisciplinary clinic &quot;Reaviz&quot; &quot;</name>
      <address>
        <city>Samara</city>
        <zip>443011</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Oncology dispensary No.2 Oncology department&quot;</name>
      <address>
        <city>Sochi</city>
        <zip>354057</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Scientific Centre for Specialized Medical Care (oncological) Chemotherapy&quot;</name>
      <address>
        <city>St Petersburg</city>
        <zip>115478</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Saint Petersburg City Oncology Clilnic &quot;</name>
      <address>
        <city>St Petersburg</city>
        <zip>198255</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;SBIH of YR &quot;&quot;Clinical oncology hospital&quot;&quot; chemotherapy department&quot;</name>
      <address>
        <city>Yaroslavl</city>
        <zip>150054</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;H. Valle de Hebrón Servicio de Oncología - (VHIR)&quot;</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Hospital de la Santa Creu I Sant Pau Oncología Medica&quot;</name>
      <address>
        <city>Barcelona</city>
        <zip>08041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital de la Santa Creu I Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Hospital Uni. Reina Sofía - Hospital Provincial Departamento de Oncología Médica&quot;</name>
      <address>
        <city>Cordoba</city>
        <zip>14004</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;INSTITUTO CATALAN DE ONCOLOGÍA - ICO Oncología Médica&quot;</name>
      <address>
        <city>Hospitalet de Llobregat</city>
        <zip>08908</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Hospital Universitario Ramón y Cajal Servicio de Oncologia Médica&quot;</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;HOSPITAL 12 DE OCTUBRE Servicio Oncología Médica&quot;</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Hospital Universitario Marqués de Valdecilla oncología medica&quot;</name>
      <address>
        <city>Santander</city>
        <zip>39008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;H.VIRGEN DEL ROCIO Servicio de Oncología Médica&quot;</name>
      <address>
        <city>Sevilla</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;H. GENERAL DE VALENCIA Servicio de Oncología Médica&quot;</name>
      <address>
        <city>Valencia</city>
        <zip>46014</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Hospital Universitario Miguel Servet Edif. de maternidad planta 8. Servicio de Oncología Médica &quot;</name>
      <address>
        <city>Zaragoza</city>
        <zip>50009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Cherkasy Regional Oncological Dispensary Regional Clinical Oncological Centre&quot;</name>
      <address>
        <city>Cherkassy</city>
        <zip>18009</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;MI &quot;&quot;Dnipropetrovsk City Multi-field Clinical Hospital #4&quot;&quot; Department of Oncology&quot;</name>
      <address>
        <city>Dnipro</city>
        <zip>49102</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;LLC Ukrainian Center of Tomotherapy &quot;Tomoclinic&quot;, Chemoteraphy Department&quot;</name>
      <address>
        <city>Kropyvnytskyi</city>
        <zip>25011</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;National Cancer Institute Department of minimally invasive and endoscopic surgery, interventional radiology &quot;</name>
      <address>
        <city>Kyiv</city>
        <zip>03022</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Medical Center n.a. Acad. Spizhenko &quot;Syber Clinic Spizhenko&quot;&quot; Department of Oncology&quot;</name>
      <address>
        <city>Kyiv</city>
        <zip>08112</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Clinical and diagnostic Centre of Medics-rey Inter. Group LLC Hospital of Israeli Oncology &quot;LISOD&quot;</name>
      <address>
        <city>Kyiv</city>
        <zip>08720</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>&quot;Podillia Regional Oncology Centre Chemotherapy Department&quot;</name>
      <address>
        <city>Vinnitsya</city>
        <zip>21029</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Brazil</country>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Poland</country>
    <country>Puerto Rico</country>
    <country>Russian Federation</country>
    <country>Spain</country>
    <country>Ukraine</country>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>January 29, 2021</study_first_submitted>
  <study_first_submitted_qc>February 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 3, 2021</study_first_posted>
  <last_update_submitted>August 2, 2021</last_update_submitted>
  <last_update_submitted_qc>August 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>trifluridine/tipiracil</keyword>
  <keyword>TAS102</keyword>
  <keyword>bevacizumab</keyword>
  <keyword>avastin</keyword>
  <keyword>RAS status (wild type, mutant)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Trifluridine</mesh_term>
    <mesh_term>Bevacizumab</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

